Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Lower back pain (LBP) poses a significant challenge for cricketers of all standards, often leading to rehabilitation periods exceeding eight months and potential termination of the playing season. Despite the identification of modifiable risk factors and interventions in previous studies, a comprehensive review of the past decade is absent. With the introduction of shorter formats like Twenty20 (T20) and the rise of franchise cricket, an updated evaluation of risk factors and interventions for preventing and treating LBP in cricketers is needed. This study critically assesses and summarises current understanding in this area, incorporating previous recommendations and considering the evolving cricket landscape. A systematic review was conducted using databases such as SportsDiscus, MEDLINE, CINAHL, ISI Web of Knowledge, and Cochrane Library. Key terms related to LBP in cricketers were utilised. The Down and Black quality assessment tool, in addition to van Tulder's criteria for levels of evidence, was applied. The quantitative analysis involved meta-analyses conducted using IBM SPSS Statistics for Windows, Version 29 (Released 2023; IBM Corp., Armonk, New York). Sixteen studies, of which 15 were of high quality, investigated risk factors associated with LBP. One low-quality randomised controlled trial examined LBP treatment. The meta-analysis revealed significant associations between LBP and increased workload, decreased bone mineral density, and poor lumbo-pelvic control through increased side flexion during the bowling action. Strong evidence supported the association between the presence of bone marrow oedema (BMO) and LBP. Bone marrow oedema on magnetic resonance imaging (MRI) provides an early indicator before the development of stress fractures, serving as a valid and reliable screening tool. Workload monitoring plays a crucial role in identifying high-risk bowlers. However, further research is needed to establish causal relationships among several other risk factors outlined. Additionally, addressing the scarcity of high-quality interventional studies is of utmost importance.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11955932 | PMC |
| http://dx.doi.org/10.7759/cureus.79869 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Major ABO-Incompatible Platelet Transfusions Are Associated With Brain Ischemia After Intracerebral Hemorrhage.
Stroke
September 2025
Department of Neurology, Vagelos College of Physicians and Surgeons, Columbia University, New York. (F.C.P., M.R., M.S., A.K., S.G., S.A., S.P., J.C., D.J.R.).
Background: Major ABO-incompatible platelet transfusions are associated with poor intracerebral hemorrhage (ICH) outcomes, yet drivers for this relationship remain unclear. Brain magnetic resonance imaging (MRI) ischemic lesions after ICH are neuroimaging biomarkers of secondary brain injury and are associated with poor outcomes. Given that ABO-incompatible platelet transfusions can induce immune complex formation, thrombo-inflammation, and endothelial barrier disruption, factors that could exacerbate cerebral ischemia, we explored whether major ABO-incompatible platelet transfusions are risk factors for ischemic lesions on brain MRI after ICH.
View Article and Find Full Text PDFIn-Flight Deterioration Occurs Early in Aeromedical Trauma Patients.
Emerg Med Australas
October 2025
Australian Centre for Health Services Innovation, School of Public Health & Social Work, Queensland University of Technology, Brisbane, Queensland, Australia.
Reliably defining the risk of adverse in-flight events in aeromedical trauma patients could enable more informed pre-departure treatment and guide central asset allocation to achieve better system-level outcomes. Unfortunately, the current literature base specifically examining the in-flight period is sparse. Flight duration is often considered a proxy for the risk of in-flight deterioration; however, there is limited data to support this commonly held assumption.
View Article and Find Full Text PDFLarge-Scale Proteomics-Based Risk Score for the Prediction of Incident Cardio-Kidney-Metabolic Disease Risk.
Circ Genom Precis Med
September 2025
Division of Cardiology, Emory University School of Medicine, Atlanta, GA. (A.K.Y., A.C.R., L.S.S., A.A.Q., Y.V.S.).
Background: Cardio-kidney-metabolic (CKM) disease represents a significant public health challenge. While proteomics-based risk scores (ProtRS) enhance cardiovascular risk prediction, their utility in improving risk prediction for a composite CKM outcome beyond traditional risk factors remains unknown.
Methods: We analyzed 23 815 UK Biobank participants without baseline CKM disease, defined by -Tenth Revision codes as cardiovascular disease (coronary artery disease, heart failure, stroke, peripheral arterial disease, atrial fibrillation/flutter), kidney disease (chronic kidney disease or end-stage renal disease), or metabolic disease (type 2 diabetes or obesity).
Sex- and gender-responsive management of anxiety disorders: future pathways for research, education, policy and practice.
Med J Aust
September 2025
University of New South Wales, Sydney, NSW.
Anxiety disorders are the most prevalent mental illness in Australia and are more common in women relative to men, as well as transgender and gender diverse people relative to cisgender people. Sex and gender differences in anxiety prevalence are likely driven by a combination of factors including differential exposure to different types of stressors and trauma, gendered enculturation of different coping responses and perceived stigma of mental illness, differences in medical comorbidities, and differences in symptom presentations. The established impact of gonadal hormone changes on anxiety risk and symptom presentation across the female lifespan underscore the need for sex- and gender-responsive management of anxiety disorders.
View Article and Find Full Text PDFAge-Dependent Contributions of Rare and Common Genetic Variation in Atrial Fibrillation.
Circ Genom Precis Med
September 2025
Feinberg School of Medicine, Northwestern University, Chicago, IL (Z.C., P.G., A.G., G.W.).
Background: Genetic variation contributes to atrial fibrillation (AF), but its impact may vary with age. The Research Program contains whole-genome sequencing of data from 100 574 adult participants with linked electronic health records.
Methods: We assessed clinical, monogenic, and polygenic associations with AF in a cross-sectional analysis, stratified by age: <45 years (n=22 290), 45 to 60 years (n=26 805), and >60 years (n=51 659).